Across TCGA pan-cancer cohorts, OR51A10P RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OR51A10P’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where OR51A10P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OR51A10P is over-expressed in tumor.
KIRC are the cancer types where OR51A10P tumor–normal differential expression is most reproducible.